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Data obtained from net organ balance studies of glucose pro-
duction lead to the classic view according to which glucose
homeostasis is mainly ensured by the liver. Hence, these
studies concluded that renal glucose production only plays a
significant role during acidosis and prolonged starvation.
These data were not in accordance with some clinical and
biochemical evidence.
As a matter of fact, blood flow and gluconeogenic-enzyme
equipment in the renal cortex are compatible, with a gluco-
neogenic activity similar to that of the liver [1]. Moreover,
renal failure was shown to be the first cause of hypoglycemia
after insulin therapy [2], suggesting the importance of this
organ in blood glucose regulation.
The magnitude of renal glucose release and its role in various
physiological and pathological circumstances were recently
reconsidered in the light of new data on renal glucose release
and uptake obtained by the combination of systemic and
renal glucose arteriovenous balance and deuterated glucose
dilution. These data now conduce one to consider that renal
gluconeogenesis substantially participates in postabsorptive
glucose production and that its role in adaptation is of first
relevance. The present paper refers to recently published
reviews on this topic [1,3].
Hepatic and renal gluconeogenesis in the
postabsorptive phase
Glucose oxidation accounts for 50% of energy expenditure
during the postabsorptive phase. Eighty percent of glucose
utilization is located in insulin-insensitive tissues (mainly the
brain) and the remaining 20% in insulin-sensitive tissues.
Glucose requirements after an overnight fast are ensured by
endogenous glucose production, which is approximately
10–11 µmol/kg/min [1]. According to data obtained from net
organ balance studies of glucose production, the liver was
considered the quasi-exclusive site of glucose production. As
a matter of fact, net renal balance of glucose studies in
healthy humans showed little or no net glucose release by the
kidneys [4–6]. As a consequence, hepatic glucose produc-
tion was considered to be ensured by hepatic glycogenolysis
(75%) and by gluconeogenesis (25%) [7].
Review
Bench-to-bedside review: Glucose production from the kidney
Noël Cano
Service d’Hépatogastroenterologie et Nutrition, Clinique Résidence du Parc, Rue Gaston Berger, 13010 Marseille, France
Correspondence: Noël Cano, njm.cano@wanadoo.fr
Published online: 7 June 2002 Critical Care 2002, 6:317-321
This article is online at http://ccforum.com/content/6/4/317
© 2002 BioMed Central Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X)
This article is based on a presentation at the Lactate Satellite Meeting held during the 8th Indonesian–International Symposium on Shock & Critical
Care, Bali, Indonesia, 24 August 2001.
Abstract
Data obtained from net organ balance studies of glucose production lead to the classic view according
to which glucose homeostasis is mainly ensured by the liver, and renal glucose production only plays a
significant role during acidosis and prolonged starvation. Renal glucose release and uptake, as well as
the participation of gluconeogenic substrates in renal gluconeogenesis, were recently re-evaluated
using systemic and renal arteriovenous balance of substrates in combination with deuterated glucose
dilution. Data obtained using these methods lead one to reconsider the magnitude of renal glucose
production as well as its role in various physiological and pathological circumstances. These findings
now conduce one to consider that renal gluconeogenesis substantially participates in postabsorptive
glucose production, and that its role in glucose homeostasis is of first importance.
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New data have been obtained during the past 5 years con-
cerning the proportion of postabsorptive glucose release due
to glycogenolysis and gluconeogenesis, on one hand, and
the respective participation of the liver and the kidney due to
gluconeogenesis, on the other. Different to the liver, the
kidney does not contain a substantial amount of glycogen in
healthy subjects. While the liver produces glucose from both
glycogenolysis and gluconeogenesis, therefore, gluconeoge-
nesis accounts for the whole renal glucose release.
The magnitude of postabsorptive glycogenolysis was recently
re-evaluated using measurements of liver glycogen content
by nuclear magnetic resonance [8]. These studies showed
that glycogenolysis accounted for 45% of hepatic glucose
release, instead of the earlier determined 25%. These find-
ings were in accordance with the report that overall glucose
release due to gluconeogenesis, as calculated from the iso-
topic dilution method, accounts for 54% of overall glucose
release [9].
The relative contribution of the liver and the kidney to post-
absorptive gluconeogenesis were recently re-evaluated.
According to carbohydrate metabolism, the kidney can be
considered as two distinct organs: the medulla, which is
poorly vascularized and which is a site of glycolysis; and the
cortex, which is a gluconeogenic organ [10]. The net organ
balance of glucose thus does not reflect renal glucose
release, but the difference between renal glucose release
(mainly by the cortex) and renal glucose uptake (mainly by the
medulla).
Glucose renal release was recently calculated using net renal
glucose balance together with deuterated glucose dilution.
These data, reviewed by Gerich et al. [1], showed that renal
glucose release was responsible for a mean of 20% of
endogenous glucose release [11–21]. As a consequence,
one may now consider that postabsorptive systemic glucose
release is ensured by hepatic glycogenolysis (50%), by
hepatic gluconeogenesis (30%) and by renal gluconeo-
genesis (20%) (Fig. 1).
These data are in accordance with the report that, during liver
transplantation in humans [22], glucose release represents
36% of basal levels 10 min after removal of the liver. Further-
more, Joseph et al. showed that extra-hepatic glucose release
reached 54% of basal levels after 60 min. Such an increase
of glucose release during the absorptive phase was associ-
ated with an increase in plasma counter-regulatory hormones
and with a stabilization of the plasma levels of gluconeogenic
substrates, particularly lactate and glycerol.
Substrates of renal gluconeogenesis
The main precursor for renal gluconeogenesis is lactate,
followed by glutamine and glycerol [1]. The renal uptakes of
these three substrates were recently reported to be
2.4 ± 0.5, 0.7 ± 0.2 and 0.6 ± 0.3 µmol/kg/min [20]. Table 1
presents the substrate contribution to renal gluconeogenesis
as measured using arteriovenous renal glucose and substrate
balances together with renal glucose release measurement
using deuterated glucose dilution. According to these data,
lactate accounted for approximately 50% of renal gluconeo-
genesis. It can be calculated that renal glucose release from
lactate is equivalent to 50% of overall lactate conversion to
glucose [1]. These data underline the major role of the
kidneys in the Cori cycle (Fig. 2). One-half of glucose produc-
tion within the Cori cycle actually takes place in the kidney.
Recent studies were devoted to the participation of amino
acids in renal glucose production. During the postabsorptive
phase, glutamine and alanine incorporation to renal gluconeo-
genesis was reported to respectively account for 73 and 4%
of their overall incorporation into glucose [15]. These findings
clearly demonstrate that gluconeogenesis from glutamine
occurs primarily in the kidney, whereas gluconeogenesis from
alanine mainly occurs in the liver. The determinism of such
organ selectivity deserves some comments. Differences in
Figure 1
Renal glucose production measured using renal glucose balance or
renal glucose balance together with deuterated glucose dilution. Data
from [1].
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Table 1
Renal gluconeogenic substrates determined using
arteriovenous renal glucose and substrate balance together
with renal glucose release measurement using deuterated
glucose dilution
% of renal glucose release
Reference Lactate Glycerol Glutamine Alanine Unknown
[1] 55 17 13 4 11
[19] 15
[20] 40 10 20 0 40substrate availability may explain the variations of gluconeo-
genesis sources from one organ to another. Glutamine is thus
largely taken up by the kidneys (60% of postabsorptive renal
amino acid uptake [23]), while in the splanchic bed glutamine
is first taken up by the intestine, which releases alanine in the
portal stream [24].
It was more recently suggested that differences in amino acid
transport in each organ may also influence the sources of glu-
coneogenesis [20]. As a matter of fact, glutamine transport
depends on the A amino acid transport system in tubular cells
and on the N system in hepatocytes [25]. As the A system but
not the N system is under the control of insulin, glucagon and
catecholamines [26], the aptitude of renal gluconeogenesis to
respond to hormone stimulation may be greater than that of
liver gluconeogenesis. Moreover, one can consider that renal
gluconeogenesis from glutamine released by the muscle real-
izes a glutamine–glucose cycle similar to the alanine–glucose
cycle involving the muscle and the liver [3].
Adaptation of gluconeogenesis
Hormone regulation
The effect of physiological hyperinsulinemia was assessed
during hyperinsulinemic euglycemic clamp experiments in
normal volunteers using organ balance measurement tech-
niques in combination with an isotopic tracer [14]. In the
kidney, insulin infusion (0.6 mU/kg/min) induced a reduction
by 60% of glucose release and gluconeogenesis from gluta-
mine. In the liver, glucose release and gluconeogenesis from
glutamine were only decreased by 48 and 23%, respectively.
Insulin increased systemic glutamine release, uptake, and
clearance but did not affect renal glutamine uptake and
release, suggesting that renal glutamine oxidation was
increased [14].
Liver gluconeogenesis and glycogenolysis, and renal gluconeo-
genesis were studied using a similar experimental protocol [21].
During a 180-min insulin infusion (0.25 mU/kg × min), a rapid
(30 min) suppression of endogenous glucose production was
observed. Such an early decrease of endogenous glucose
release was due to the simultaneous inhibition of liver
glycogenolysis and renal gluconeogenesis. Hepatic gluconeo-
genesis decreased later (120–180 min). Considering the effect
of insulin infusion on gluconeogenic substrates in each organs,
it was observed that the net renal uptake of lactate decreased
earlier (30 min) than the splanchnic uptake of lactate and
alanine (120–180 min), and that both renal and splanchnic
glycerol uptake decreased after 90 min of insulin infusion [21].
It can be deducted from these two studies that renal
gluconeogenesis is more sensitive to insulin than liver
gluconeogenesis. Moreover, these data underlined the role of
decreased lactate uptake in the rapid decrease of renal
glucose release in response to insulin infusion.
Glucagon was shown to increase systemic and hepatic
glucose release but to have no effect on renal glucose release
[16]. This effect of glucagon on glucose production was
mainly attributed to an increase of gluconeogenesis from glut-
amine. During the infusion of glucagon, overall glucose pro-
duction from glutamine and hepatic glucose production from
glutamine were respectively increased by 36 and 280%, while
renal glucose production from glutamine was unaffected.
Glucagon infusion may thus be an unusual circumstance
during which substantial hepatic gluconeogenesis from gluta-
mine may occur. It must be pointed out, however, that hepatic
glucose release in these experiments was assumed to be
equal to systemic glucose release minus renal glucose
release. Consequently, one cannot exclude the participation
of the gut, which was recently shown to contain the complete
enzymatic equipment for gluconeogenesis [27,28], in
extrarenal glucose production from glutamine.
Epinephrine infusion was conversely shown to induce a
greater than twofold increase in systemic and renal glucose
production, and to stimulate overall glutamine and alanine
incorporation into glucose [15]. During a 2-hour infusion of
epinephrine, different responses were observed in the kidney
as compared with the liver: a sustained increase of renal
glucose production was observed, whereas the hepatic
response was transient.
The stimulation of systemic glucose production from gluta-
mine was mainly related to renal gluconeogenesis (90% of
total glutamine gluconeogenesis). The stimulation of alanine
gluconeogenesis, on the contrary, only occurred in the liver
[15]. The stimulation of renal gluconeogenesis during the epi-
nephrine infusion may involve free fatty acids, the plasma con-
centrations of which were found to be increased during
epinephrine infusion.
Starvation
As compared with the postabsorptive state, a 24-hour starvation
state is characterized by a 60% decrease in both endogenous
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Figure 2
Renal contribution to endogenous glucose release from lactate during
the postabsorptive phase. Data from [1].
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50% 50%glucose production and utilization. During such a fasting state,
glycogen stores are depleted and glucose production only
derives from gluconeogenesis. Studies using net glucose
balance measurements reported that the liver accounted for
80–90% of glucose production, and the kidney for 10–20% [7].
The participation of the kidney to glucose production during
starvation was recently investigated using the arteriovenous
balance technique across kidneys and the splanchnic area
combined with intravenous infusion of labeled glucose. These
studies showed that, after 60 hours of fasting in healthy indi-
viduals, renal glucose production may account for 20–25%
of whole-body glucose turnover [17]. The increase in fasting
duration from 12 to 60 hours was associated with a 2.5-fold
increase in renal glucose release while, in the same time,
hepatic glucose release decreased by 25%. These data
underline the role of the kidney in glucose homeostasis
during starvation and explain the increased risk of hypo-
glycemia during renal failure [2].
Diabetes
Type 1 diabetes mellitus and type 2 diabetes mellitus are
characterized by an increase in systemic, hepatic and renal
glucose release [1]. In type 2 diabetes, a 300% increase in
glucose release was reported in diabetics as compared with
controls. This increment involved, in the same proportion,
renal and hepatic glucose release [13].
It must be pointed out that renal glucose uptake was
markedly increased during diabetes, resulting in a net renal
glucose uptake. The fate of such an increase in glucose
uptake by the kidney during diabetes is poorly known. It has
been proposed that this glucose overload may contribute to
the glycogen deposit that has been observed in these condi-
tions [1]. In diabetic subjects [13], as in non-diabetic sub-
jects [12,15], it was reported that renal glucose uptake was
inversely correlated with free fatty acid uptake, suggesting
the existence of a renal glucose–fatty acid cycle [12].
Renal gluconeogenesis during hypoglycemia
Hypoglycemia is frequent during chronic renal failure and has
been attributed to multiple factors including abnormal liver
gluconeogenesis [29]. However, the suppression of the role
of the kidney in glucose homeostasis may be determinant. In
healthy subjects, renal glucose release was studied in the
postabsorptive phase and during a 180-min insulin clamp
inducing either euglycemia or hypoglycemia [20]. As com-
pared with euglycemia, hypoglycemia was associated with an
80% increase in systemic glucose release. During hypo-
glycemia, a 70% increase in renal glucose release, reaching
52.5% of endogenous glucose release, was observed.
This increase in renal gluconeogenesis during hypoglycemia
was associated with an increase in the renal uptake of circu-
lating gluconeogenic substrates. Plasma lactate, glycerol, and
glutamine accounted for 30, 19 and 11%, respectively, of the
increase of renal glucose release. These data suggest that
the increase in renal gluconeogenesis from circulating sub-
strates is integrated in the mechanism counteracting hypo-
glycemia [20]. It must be underlined that renal gluconeogenic
precursors other than lactate, glutamine and glycerol repre-
sented 40% of renal gluconeogenesis. The participation of
amino acids other than glutamine in renal gluconeogenesis,
which has been reported in experimental acidosis [30,31],
has not yet been investigated during hypoglycemia.
Conclusions
New data on renal glucose release and uptake obtained by
the combination of systemic and renal glucose arteriovenous
balance and deuterated glucose dilution make it possible to
re-evaluate the role of the kidney in glucose homeostasis.
Renal glucose release thus appeared to be of the same order
of magnitude as splanchnic glucose release during the
postabsorptive period. Furthermore, the peculiarity of renal
glucose release appeared to be its sensitivity to hormone
action, which gives the kidney a pre-eminent role in glucose
homeostasis during various physiological and pathological
states. Moreover, the reappraisal of renal gluconeogenesis
together with studies on gluconeogenic substrates provided
evidence for a key role of the kidney in interorgan glucose
metabolism, and particularly in the Cori cycle and in gluco-
neogenesis from glutamine. These findings help the under-
standing of abnormal glucose homeostasis during chronic
renal failure.
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